HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype.

Abstract
Carnitine-acylcarnitine translocase deficiency, a rare beta-oxidation defect, is manifest in most cases by cardiomyopathy and death in early childhood. We report an affected patient, 3 years of age, who has had no serious complications. The residual enzyme activity in fibroblasts was higher than in previously reported patients, which may explain the benign clinical course.
AuthorsA A Morris, S E Olpin, M Brivet, D M Turnbull, R A Jones, J V Leonard
JournalThe Journal of pediatrics (J Pediatr) Vol. 132 Issue 3 Pt 1 Pg. 514-6 (Mar 1998) ISSN: 0022-3476 [Print] United States
PMID9544911 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Blood Glucose
  • Carnitine Acyltransferases
  • Carnitine
Topics
  • Blood Glucose
  • Carnitine (blood)
  • Carnitine Acyltransferases (deficiency)
  • Humans
  • Infant, Newborn
  • Male
  • Metabolism, Inborn Errors (genetics)
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: